http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#head http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#assertion http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#assertion http://bio2rdf.org/drugbank:DB00214 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB00622 http://bio2rdf.org/drugbank:DB00622 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00214_DB00622 http://bio2rdf.org/drugbank_resource:DB00214_DB00622 http://purl.org/dc/terms/identifier drugbank_resource:DB00214_DB00622 http://bio2rdf.org/drugbank_resource:DB00214_DB00622 http://purl.org/dc/terms/title DDI between Torasemide and Nicardipine - Nicardipine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Nicardipine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00214_DB00622 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00214_DB00622 http://www.w3.org/2000/01/rdf-schema#label DDI between Torasemide and Nicardipine - Nicardipine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Nicardipine is initiated, discontinued or dose changed. [drugbank_resource:DB00214_DB00622] http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#provenance http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#publicationInfo http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#signature.MCwCFFaY2uyRXm5J http://purl.org/nanopub/x/hasPublicKey MIIBtzCCASwGByqGSM44BAEwggEfAoGBAP1/U4EddRIpUt9KnC7s5Of2EbdSPO9EAMMeP4C2USZpRV1AIlH7WT2NWPq/xfW6MPbLm1Vs14E7gB00b/JmYLdrmVClpJ+f6AR7ECLCT7up1/63xhv4O1fnxqimFQ8E+4P208UewwI1VBNaFpEy9nXzrith1yrv8iIDGZ3RSAHHAhUAl2BQjxUjC8yykrmCouuEC/BYHPUCgYEA9+GghdabPd7LvKtcNrhXuXmUr7v6OuqC+VdMCz0HgmdRWVeOutRZT+ZxBxCBgLRJFnEj6EwoFhO3zwkyjMim4TwWeotUfI0o4KOuHiuzpnWRbqN/C/ohNWLx+2J6ASQ7zKTxvqhRkImog9/hWuWfBpKLZl6Ae1UlZAFMO/7PSSoDgYQAAoGAETGrDm8R3KfndKRj7ttr3jVhhstI6/2Ey0ER9F5kdx7Hrd6eolq7yWzPzf2H754tdZxICzxYcdawBbL2ZUzFjWwXTNUQC3+e6evKPJyNELubnZcA+8TxIIwicBnw3Ku6mSeI8SUVr5SBV1VeJoSu/ahldv562IdBR8IagmzuT3Y= http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#signature.MCwCFFaY2uyRXm5J http://purl.org/nanopub/x/hasSignature MCwCFFaY2uyRXm5JD/rQVkzU6oXYRLNkAhQjoEIExAggTAqrS4vNYHM8l7PSIg== http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#signature.MCwCFFaY2uyRXm5J http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://purl.org/dc/terms/created 2018-03-30T11:12:24.605+02:00 http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY#signature.MCwCFFaY2uyRXm5J http://bio2rdf.org/drugbank_resource:DB00214_DB00622_nanopub.RAWd_iWmzAENOtqBp2KwJ5HHWzcotVLXQ8zoiT72_PVRY http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234